Top in endocrinology: Obesogenic drug prescription rate, COVID-19 and diabetes in children

Recent data revealed that 20% of adults are prescribed obesogenic medications, with beta-blockers and diabetes drugs most commonly prescribed. A report on the data was the top story in endocrinology last week.

In another top story, new data showed that children who had COVID-19 were more likely to develop diabetes than children without COVID-19 and those who had a non-COVID-19 acute respiratory infection.

Read these and more top stories in endocrinology below:

20% of adults use medications that cause weight gain

One in five adults in the National Health and Nutrition Examination Survey 2017-2018 reported prescriptions for obesogenic medications, according to results published in Obesity. Read more.

Children with COVID-19 more likely to receive new diabetes diagnosis

Children who had a COVID-19 infection have a higher risk for developing diabetes compared with those who did not contract COVID-19, according to study findings published in Morbidity and Mortality Weekly Report. Read more.

Time in glucose target range may decline after COVID-19 vaccine in type 1 diabetes

The first dose of a COVID-19 vaccine can cause a decline in interstitial glucose time in range for adults with type 1 diabetes, according to study findings published in Diabetic Medicine. Read more.

HbA1c remains suboptimal for most people with type 1 diabetes

In an analysis of HbA1c data from 22 nations, most children and adults with type 1 diabetes do not have an HbA1c of less than 7.5%, though glycemic control varies greatly by age and country, according to study data. Read more.

‘Variable impacts’ on calcium absorption with prebiotic supplement after gastric bypass

Postmenopausal women who received a daily prebiotic supplement years after gastric bypass saw no change in calcium absorption compared with women who received placebo, though some differential responses were observed in the prebiotic group. Read more.